KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) EPS (Weighted Average and Diluted) (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of EPS (Weighted Average and Diluted) data on record, last reported at $0.71 in Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 40.34% year-over-year to $0.71; the TTM value through Dec 2025 reached $3.55, down 19.86%, while the annual FY2025 figure was $3.55, 19.86% down from the prior year.
  • EPS (Weighted Average and Diluted) reached $0.71 in Q4 2025 per ZBH's latest filing, down from $1.16 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $2.0 in Q4 2023 and bottomed at -$0.62 in Q4 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.82, with a median of $0.88 recorded in 2024.
  • Peak YoY movement for EPS (Weighted Average and Diluted): plummeted 264.71% in 2022, then soared 422.58% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.17 in 2021, then tumbled by 264.71% to -$0.62 in 2022, then skyrocketed by 422.58% to $2.0 in 2023, then crashed by 40.5% to $1.19 in 2024, then plummeted by 40.34% to $0.71 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were $0.71 in Q4 2025, $1.16 in Q3 2025, and $0.77 in Q2 2025.